ArticleCase reports in immunology2018

Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients.

Enrico Brunetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.